Certara(us:CERT)

9.87

-0.30%

Updated on 2025-04-02

Open:9.85
Close:9.87
High:9.97
Low:9.56
Prev Close:9.90
Volume:1.75M
Turnover:17.21M
Turnover Ratio:1.09%
Shares:161.02M
MarketCap:1.59B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3023811985090574.50%2669112
2024-03-3123311942789574.55%277891
2023-12-3122711814656073.91%2876102
2023-09-3022510665127566.72%2564112
2023-06-3024210741683467.23%3479108
2023-03-3122410762962567.43%388380
2022-12-312249381175458.81%4067103
2022-09-3020312050344175.42%446477
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Blackrock Inc.134233808.34%-565446-4.04%
2024-06-30Vanguard Group Inc124990327.77%-56348-0.45%
2024-06-30Mubadala Investment Co Pjsc96153845.98%0
2024-06-30Baillie Gifford & Co83573015.19%-180243-2.11%
2024-06-30Wasatch Advisors Lp73648654.58%244002049.55%
2024-06-30Geneva Capital Management Llc54728173.40%106861824.26%
2024-06-30William Blair Investment Management, Llc52168883.24%-502902-8.79%
2024-06-30Clearbridge Investments, Llc40873972.54%-85798-2.06%
2024-06-30Jpmorgan Chase & Co40492952.52%-309850-7.11%
2024-06-30State Street Corp35572882.21%-353-0.01%

About

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Address:4 Radnor Corporate Center,Suite 350

Market Movers